Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Martin Midstream Partners | MMLP | Aug 30, 2024 | 3.53 | -1.40 |
Marvell Technology | MRVL | Aug 30, 2024 | 76.24 | +9.16 |
Masco | MAS | Aug 30, 2024 | 79.56 | +0.89 |
Masimo | MASI | Aug 30, 2024 | 117.52 | +0.33 |
Massimo Group | MAMO | Aug 30, 2024 | 3.27 | +5.11 |
MasTec | MTZ | Aug 30, 2024 | 113.13 | +2.08 |
Mastech Digital | MHH | Aug 30, 2024 | 9.63 | -3.12 |
Masterbrand | MBC | Aug 30, 2024 | 16.04 | +1.71 |
Mastercard | MA | Aug 30, 2024 | 483.34 | +0.53 |
MasterCraft Boat | MCFT | Aug 30, 2024 | 18.53 | -0.70 |
Matador Resources | MTDR | Aug 30, 2024 | 56.72 | -2.43 |
Match Group | MTCH | Aug 30, 2024 | 37.21 | +0.05 |
Materialise ADR | MTLS | Aug 30, 2024 | 5.35 | -1.29 |
Materials Alphadex First Trust | FXZ | Aug 30, 2024 | 65.67 | +0.24 |
Materials ETF Vanguard | VAW | Aug 30, 2024 | 206.38 | +1.05 |
Materials Select Sector SPDR | XLB | Aug 30, 2024 | 94.28 | +1.09 |
Materion | MTRN | Aug 30, 2024 | 116.04 | +0.64 |
Matinas Biopharma | MTNB | Aug 30, 2024 | 0.09 | 0.00 |
Matrix Service | MTRX | Aug 30, 2024 | 9.96 | +0.10 |
Matson | MATX | Aug 30, 2024 | 138.30 | +1.01 |
Mattel | MAT | Aug 30, 2024 | 18.98 | -0.84 |
Matterport A | MTTR | Aug 30, 2024 | 4.53 | +0.67 |
Matthews International A | MATW | Aug 30, 2024 | 25.33 | -0.28 |
Maui Land & Pineapple | MLP | Aug 30, 2024 | 26.01 | +8.92 |
Mawson Infrastructure | MIGI | Aug 30, 2024 | 1.30 | -4.41 |
Maxcyte | MXCT | Aug 30, 2024 | 4.32 | +0.23 |
Maxeon Solar Technologies | MAXN | Aug 30, 2024 | 0.11 | +3.64 |
Maximus | MMS | Aug 30, 2024 | 92.26 | -0.16 |
MaxLinear | MXL | Aug 30, 2024 | 15.18 | +10.08 |
Mayville Engineering | MEC | Aug 30, 2024 | 19.31 | -0.52 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.